Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Process Hold Time and Sample Tracking – V 2.0

Posted on By

API Manufacturing: SOP for Process Hold Time and Sample Tracking – V 2.0

Standard Operating Procedure for Process Hold Time and Sample Tracking in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/105/2025
Supersedes SOP/API/105/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To establish a standardized procedure for monitoring and controlling hold times for in-process materials during various stages of API manufacturing and to ensure traceable tracking of IPC and QC samples from collection to final disposition.

2. Scope

This SOP applies to all hold periods of intermediates, wet cake, dry powder, filtrates, and solutions before further processing, and to all IPC/QC samples drawn and submitted during batch manufacturing in the API facility.

3. Responsibilities

  • Production Chemist: Record start and end of hold periods and collect samples as per schedule.
  • QC Analyst: Receive and acknowledge samples, track test results, and report timelines.
  • QA Officer: Review and approve hold time extensions, ensure hold times comply with validated limits.
See also  API Manufacturing: SOP for Work-Up Procedure After Reaction Completion - V 2.0

4. Accountability

Production Head is accountable for in-process hold time control. QA Head is responsible for procedural compliance and timely oversight of sample tracking.

5. Procedure

5.1 Hold Time Definition

  1. Hold time is defined as the duration between the completion of a process step and initiation of the next step.
  2. Refer to the approved Master Formula Record (MFR) for allowable hold time limits per stage.

5.2 Types of Hold Times

  1. Pre-filtration solution hold
  2. Post-filtration (wet cake) hold
  3. Crude drying hold
  4. Intermediate hold during blending or sieving

5.3 Recording Hold Times

  1. Enter the start time when process is stopped or paused.
  2. Enter the end time when the next process resumes.
  3. Record total duration and reason (if applicable) in Hold Time Log (Annexure-1).
  4. If the hold exceeds approved limits, document deviation and QA shall evaluate product quality risk.

5.4 Sample Collection and Tracking

  1. Collect IPC or QC samples as per the sampling plan or when hold extends beyond 25% of validated time.
  2. Label each sample with unique Sample Code, Batch No., Date, Stage, and Sampler Initials (Annexure-2).
  3. Submit sample to QC with completed Sample Forwarding Form (Annexure-3).
  4. QC shall enter receipt in the Sample Receipt Log and assign test request reference.
See also  API Manufacturing: SOP for Monitoring Warehouse Temperature and Humidity - V 2.0

5.5 Sample Status Updates

  1. QC to update sample testing status in the tracking log within 2 hours of receipt.
  2. Any delay must be informed to QA and Production immediately.
  3. For samples under investigation or out-of-spec, QA shall initiate appropriate action.

5.6 Hold Time Extensions

  1. In case of unavoidable delay:
    • Production must raise a Hold Time Extension Request
    • QA shall evaluate based on storage conditions, stage, and risk
    • Extension may be granted with justification and supported data
  2. Record the extension in the deviation log and Hold Time Logbook.

6. Abbreviations

  • QA: Quality Assurance
  • QC: Quality Control
  • IPC: In-Process Control
  • MFR: Master Formula Record
  • SOP: Standard Operating Procedure

7. Documents

  1. Hold Time Logbook (Annexure-1)
  2. Sample Label Template (Annexure-2)
  3. Sample Forwarding Form (Annexure-3)
See also  API Manufacturing: SOP for Centrifugation Process for Wet Cake Separation - V 2.0

8. References

  • ICH Q7 – GMP Guide for Active Pharmaceutical Ingredients
  • 21 CFR Part 211 – US FDA cGMP
  • WHO TRS 986 – Annex 2 GMP Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Hold Time Logbook

Date Batch No. Stage Start Time End Time Duration (hrs) Reason QA Verified
13/04/2025 API-20250413 Post-Filtration 11:00 15:00 4 Waiting for QC release

Annexure-2: Sample Label Template

Sample Code
Batch Number
Stage
Sampler Name
Date of Sampling

Annexure-3: Sample Forwarding Form

Date Batch No. Sample Code Test Type Qty Submitted By QC Received By
13/04/2025 API-20250413 IPC105-01 LOD 10 g Ravi Kumar

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Release New Requirement QA Head
13/04/2025 2.0 Integrated sample tracking and hold time extension protocol Audit Compliance QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: BA-BE Studies: SOP for Regulatory Inspection at Clinical Site – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version